MiR-129 reduces CDDP resistance in gastric cancer cells by inhibiting MAPK3.

Cao HY, Xiao CH, Lu HJ, Yu HZ, Hong H, Guo CY, Yuan JF

Open source

DOI
10.26355/eurrev_201908_18531
Published
2019 Aug
Container
European review for medical and pharmacological sciences
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.26355/eurrev_201908_18531,
  title = {MiR-129 reduces CDDP resistance in gastric cancer cells by inhibiting MAPK3.},
  author = {Cao HY and Xiao CH and Lu HJ and Yu HZ and Hong H and Guo CY and Yuan JF},
  year = {2019},
  journal = {European review for medical and pharmacological sciences},
  doi = {10.26355/eurrev_201908_18531},
  url = {https://doi.org/10.26355/eurrev_201908_18531}
}

RIS

TY  - JOUR
TI  - MiR-129 reduces CDDP resistance in gastric cancer cells by inhibiting MAPK3.
AU  - Cao HY
AU  - Xiao CH
AU  - Lu HJ
AU  - Yu HZ
AU  - Hong H
AU  - Guo CY
AU  - Yuan JF
PY  - 2019
JO  - European review for medical and pharmacological sciences
DO  - 10.26355/eurrev_201908_18531
UR  - https://doi.org/10.26355/eurrev_201908_18531
ER  - 

APA

HY, C., CH, X., HJ, L., HZ, Y., H, H., CY, G., & JF, Y. (2019). MiR-129 reduces CDDP resistance in gastric cancer cells by inhibiting MAPK3.. European review for medical and pharmacological sciences. https://doi.org/10.26355/eurrev_201908_18531

Source records